Literature DB >> 2894805

Tropical spastic paraparesis: clinical, immunological, and virological studies in two patients from Martinique.

M C Dalakas1, G Stone, G Elder, M Ceroni, D Madden, G Román, J L Sever.   

Abstract

Two patients from Martinique with tropical spastic paraparesis had antibodies to human T-lymphotropic virus type I (HTLV-I) in serum and spinal fluid but no antibodies to other retroviruses tested. They presented with spastic weakness of both lower extremities, hyperreflexia with upgoing toes, sphincteric dysfunction, and normal sensation. By means of agarose isoelectric focusing and selective immunoblotting we demonstrated an increased intrathecal synthesis of IgG antibodies to HTLV-I in the spinal fluid. Unique oligoclonal bands of IgG antibodies to HTLV-I were present in the cerebrospinal fluid. Using a battery of monoclonal antibodies we also found in these patients an increased number of circulating T cells that expressed activation markers. We conclude that the HTLV-I retrovirus associated with tropical spastic paraparesis has both lymphocytotropic and neurotropic properties.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2894805     DOI: 10.1002/ana.410230732

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  3 in total

1.  Treatment of HTLV-I-associated myelopathy with high-dose intravenous gammaglobulin.

Authors:  Y Kuroda; H Takashima; A Ikeda; C Endo; R Neshige; R Kakigi; H Shibasaki
Journal:  J Neurol       Date:  1991-09       Impact factor: 4.849

2.  Neuroaxonal dystrophy in HTLV-1-associated myelopathy/tropical spastic paraparesis: neuropathologic and neuroimmunologic correlations.

Authors:  E Wu; D W Dickson; S Jacobson; C S Raine
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

3.  Elevated LGI1-IgG CSF index predicts worse neurological outcome.

Authors:  Avi Gadoth; Anastasia Zekeridou; Christopher J Klein; Colton J Thoreson; Masoud Majed; Divyanshu Dubey; Eoin P Flanagan; Andrew McKeon; Sarah M Jenkins; Vanda A Lennon; Sean J Pittock
Journal:  Ann Clin Transl Neurol       Date:  2018-04-02       Impact factor: 4.511

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.